Mostrar el registro sencillo del ítem

dc.contributor.authorOrtega, Javier
dc.contributor.authorde Juan, Lucia
dc.contributor.authorSevilla, Iker A
dc.contributor.authorGarrido, Joseba M
dc.contributor.authorRoy, Álvaro
dc.contributor.authorVelasco, Carlos
dc.contributor.authorRomero, Beatriz
dc.contributor.authorDominguez-Rodriguez, Mercedes 
dc.contributor.authorPérez de Val, Bernat
dc.contributor.authorNebot, Carolina
dc.contributor.authorSáez-Llorente, José Luis
dc.contributor.authorÁlvarez, Julio
dc.contributor.authorBezos, Javier
dc.date.accessioned2023-05-08T08:12:42Z
dc.date.available2023-05-08T08:12:42Z
dc.date.issued2022-11
dc.identifier.citationFront Vet Sci. 2022 Nov 10;9:1042428.es_ES
dc.identifier.issn2297-1769es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16007
dc.description.abstractCaprine tuberculosis (TB) is a zoonosis caused by members of the Mycobacterium tuberculosis complex (MTBC). Caprine TB eradication programmes are based mainly on intradermal tuberculin tests and slaughterhouse surveillance. Different factors may affect the performance of the TB diagnostic tests used in caprine herds and, therefore, their ability to detect infected animals. The present study evaluates the effect of the fraudulent administration of two anti-inflammatory substances, dexamethasone and ketoprofen, on the performance of the TB diagnostic techniques used in goats, as well as the suitability of high performance liquid chromatography (HPLC) for their detection in hair samples. The animals (n = 90) were distributed in three groups: (1) a group treated with dexamethasone (n = 30); a second group treated with ketoprofen (n = 30); and a third non-treated control group (n = 30). Both dexamethasone and ketoprofen groups were subjected to intramuscular inoculation with the substances 48 h after the administration of bovine and avian purified protein derivatives (PPDs), that is, 24 h before the tests were interpreted. All the animals were subjected to the single and comparative intradermal tuberculin (SIT and CIT, respectively) tests, interferon-gamma release assay (IGRA) and P22 ELISA. The number of SIT test reactors was significantly lower in the dexamethasone (p = 0.001) and ketoprofen (p < 0.001) groups 72 h after the bovine PPD inoculation compared with the control group. A significantly higher number of positive reactors to IGRA was detected within the dexamethasone group (p = 0.016) 72 h after PPD administration compared to the control group. Dexamethasone and ketoprofen detection in either hair or serum samples was challenging when using HPLC since these substances were not detected in animals whose skin fold thickness (SFT) was reduced, what could be an issue if they are used for fraudulent purposes. In conclusion, the parenteral administration of dexamethasone or ketoprofen 48 h after the PPDs administration can significantly reduce the increase in SFT (mm) and subsequently the number of positive reactors to SIT test.es_ES
dc.description.sponsorshipThis study was funded by the Analysis of the long-term caprine tuberculosis eradication process and development of diagnostic tests and control measures for its improvement (GoaTBfree-UCM) Project (PID2019-105155RB-C31). JO was supported by an FPU contract-fellowship (Formación de Profesorado Universitario) from the Ministerio de Ciencia, Innovación y Universidades (FPU18/05197).es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Media es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCaprine tuberculosises_ES
dc.subjectDexamethasonees_ES
dc.subjectDiagnosises_ES
dc.subjectIntradermal tuberculin testes_ES
dc.subjectKetoprofenes_ES
dc.titleEffect of a recent parenteral dexamethasone and ketoprofen administration on the immunological diagnosis of tuberculosis in goatses_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID36439353es_ES
dc.format.volume9es_ES
dc.format.page1042428es_ES
dc.identifier.doi10.3389/fvets.2022.1042428es_ES
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España) es_ES
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.3389/fvets.2022.1042428es_ES
dc.identifier.journalFrontiers in veterinary sciencees_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-105155RB-C31es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FPU18/05197es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional